It's a trending topic: weight loss medication. But which one might be right for you? 7 News sat down with doctors from Bon ...

When I think about food noise, I’m flung back to the height of my eating disorder, when I was paralyzed by the thought of ...

Advocates are pushing back against Tricare's plan to end its coverage of weight-loss drugs for Tricare for Life beneficiaries by Aug. 31.

Makers of GLP-1 drugs, including Novo Nordisk, Eli Lilly and others, are close to releasing daily pills to help shed pounds ...

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with ...

Novo Nordisk's experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The ...

The drug. orforglipron, works on the same receptor as semaglutide (Ozempic/Wegovy), but can be taken without restrictions on food or water intake.

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Production is under way and the pill, which helped patients lose an average 16.6% of their weight, is pending regulatory approval in the U.S.

Weight loss surgery is a cheaper and more effective way than medications like Ozempic for obese patients to shed pounds, according to a Highmark Health study released Wednesday that tracked thousands ...

Jason Kelce is taking the hustle off the field. The former NFL player showed off his chiseled arm muscles after previously sharing he lost 30 pounds since retiring from the NFL in January 2024. In a ...